Global Oncothon 2026
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy
PRADO Trial: Neoadjuvant Ipilimumab Plus Nivolumab in Melanoma—5-Year Survival and Biomarker Analysis
Afreen Shariff Starts a New Position as Chair at ASCO for the ASPIRE Community of Practice
How the European Code Against Cancer Can Reduce Cancer Risk in Greece - ELLOK
Breakthrough Innovations in Frontline TNBC Care - The Breast Friends Podcast
Community Oncology Alliance Shares 2025 End of Year Update on Advocacy and Practice Support
In Memory of Kirsty Duncan: A Life Devoted to Science, Health, and Equity
The 16th World ADC London, set to convene at ExCeL London from February 23–26, 2026, stands as Europe’s premier conference dedicated to Antibody-Drug Conjugates (ADCs). The central focus of the 2026 […]
